- Novan (NASDAQ:NOVN) announces several leadership promotions and business updates.
- Paula Brown Stafford has been promoted to President and the newly created role of Chief Operating Officer. Prior to Novan in March 2017 as Chief Development Officer, she was President of the Quintiles Global Clinical Development organization.
- Dr. Carri Geer has been promoted to Senior VP and Chief Technology Officer. Dr. Geer previously worked at Merck & Co. She will report to Ms. Stafford.
- Dr. Elizabeth Messersmith, Senior VP, ha been promoted to the role of Chief Development Officer. Dr. Messersmith joined Novan as Head of Clinical Operations in May 2018 from Quark Pharmaceuticals. She will also report to Ms. Stafford.
- Dr. Nathan Stasko has stepped down as President and from the Board of Directors.
- The Company is actively engaged in business development discussions around dermatology assets and nitric oxide technology platform, with particular focus on molluscum.
- Now read: Neurocrine Biosciences: A Moat Builder
Original article